Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women

Publication Date: June 6, 2017
Last Updated: March 14, 2022

Recommendations

ACP recommends that clinicians offer pharmacologic treatment with alendronate, risedronate, zoledronic acid, or denosumab to reduce the risk for hip and vertebral fractures in women who have known osteoporosis. (SH)
565

Overview

Title

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women

Authoring Organization